Clinical Trial Update: A Study to Assess the Analgesic Efficacy and Safety of ASP0819 in Patients With Fibromyalgia [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the analgesic efficacy and safety of ASP0819 in fibromyalgia has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fibromyalgia

Drugs mentioned

• ASP0819

Snippet

Sponsor: Astellas Pharma Global Development, Inc. | Conditions: Fibromyalgia | Phase 2 | Status: COMPLETED | Results posted: 2021-03-03